<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>ITP • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="ITP • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/ITP/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/ITP/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>
    <div class="max-w-4xl mx-auto">

    <div class="flex items-center justify-center max-w-full px-6 mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1>ITP</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<!-- ITP management -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20200906125013_.png" alt=""></p>
<ul>
<li>Patients with asymptomatic mild thrombocytopenia (platelets &gt;30,000/µL without bleeding) can generally be observed without treatment.</li>
<li><strong>Corticosteroids</strong> are a first-line treatment option for patients with symptoms and/or a platelet count of &lt;30,000/µL; the majority of adults respond within 1-2 weeks.</li>
<li><strong>Intravenous immunoglobulin</strong> can be considered in patients who have failed or have contraindications to steroid therapy or require a more rapid increase in platelet counts.</li>
<li><strong>Anti-Rh(D)</strong> is an alternate treatment option in rhesus-positive non-splenectomized patients.</li>
<li><strong>Rituximab</strong> can be considered for patients who have failed initial treatment.  Splenectomy is generally reserved for refractory cases .</li>
</ul>
</div>
      
    </div>

    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Bleeding disorders/" class="peer">Bleeding Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1>Bleeding disorders</h1>
<ul>
<li>
<p>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></p>
</li>
<li>
<p><a href="/wiki/notes/ITP/">ITP</a></p>
</li>
</ul>
<!-- intrinsic vs extrinsic bleeding disorders -->
<ul>
<li>Intrinsic bleeding disorder
<ul>
<li>prolonged PTT</li>
<li>hemophilia A(8)/B: nl PT, bleeding time, plt count
<ul>
<li>replace with DDAVP and aminocaproic acid for hemophilia A</li>
<li>can also give factor 8</li>
</ul>
</li>
<li>vWF: increased PTT and bleeding time
<ul>
<li>riscocetin test for diagnosis</li>
<li>DDAVP and aminocaproic acid</li>
</ul>
</li>
</ul>
</li>
<li>Extrinsic bleeding disorder
<ul>
<li>prolonged PT/INR</li>
</ul>
</li>
<li>vitamin K, coumadin: 2</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
